The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; 19 of the 38 sources its claims cite were checked for support.
Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis
Open accessAbstract
Background Intermittent fasting (IF) and continuous energy restriction (CER) are widely used dietary approaches for metabolic dysfunction–associated steatotic liver disease (MASLD), yet their comparative efficacy remains uncertain. Methods PubMed, Embase, Web of Science, and Cochrane Central were searched from inception to August 1, 2025, for randomized controlled trials comparing intermittent fasting (IF) with continuous energy restriction (CER) in adults with NAFLD, MAFLD, or MASLD. Risk of bias was assessed using RoB 2, and weighted mean differences were pooled using random-effects models. Results Nine trials (n = 894) were included, involving time-restricted feeding (TRF), alternate-day fasting (ADF), and 5:2 fasting (whole-day fasting, WDF). Compared with CER, IF was associated with greater reductions in body weight (MD = -1.29 kg; 95% CI, -1.98 to -0.61), BMI (MD = -0.34 kg/m2; 95% CI, -0.55 to -0.13), LDL-C (MD = -0.08 mmol/L; 95% CI, -0.15 to -0.01), and controlled attenuation parameter (CAP) (MD = -15.13 dB/m; 95% CI, -28.87 to -1.39). No significant between-group differences were observed for magnetic resonance imaging–proton density fat fraction (MRI-PDFF), liver stiffness, transaminases, glucose-related indices, total cholesterol, triglycerides, or HDL-C. In subgroup analyses, WDF was associated with a greater reduction in CAP, whereas TRF appeared to be associated with greater reductions in body weight and BMI. Conclusion In patients with MASLD, intermittent fasting was associated with greater reductions in body weight, BMI, and LDL-C than continuous energy restriction.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis of 9 randomized trials (n = 894) compared intermittent fasting (IF) with continuous energy restriction (CER) in adults with MASLD. IF was associated with greater reductions in body weight, BMI, and LDL-C, but evidence for hepatic steatosis was discordant: CAP favored IF while MRI-PDFF did not, and the CAP advantage lost significance in sensitivity analyses.
Key findings
- Across 9 trials (n = 894), IF was associated with greater reductions than CER in body weight (MD = −1.29 kg; 95% CI, −1.98 to −0.61), BMI (MD = −0.34 kg/m²; 95% CI, −0.55 to −0.13), LDL-C (MD = −0.08 mmol/L; 95% CI, −0.15 to −0.01), and CAP (MD = −15.13 dB/m; 95% CI, −28.87 to −1.39).
- No significant between-group differences were found for MRI-PDFF (MD = −0.08%; 95% CI, −1.65 to 1.48), liver stiffness (MD = −0.41 kPa; 95% CI, −1.07 to 0.25), ALT (MD = −3.23 U/L; 95% CI, −6.55 to 0.09), AST (MD = −0.55 U/L; 95% CI, −3.14 to 2.04), glucose-related indices, total cholesterol, triglycerides, or HDL-C.
- Subgroup analyses suggested WDF had greater CAP reduction (MD = −21.43 dB/m; 95% CI, −36.63 to −6.24) and greater ALT/AST reductions, whereas TRF appeared to have greater body weight (MD = −1.31 kg; 95% CI, −2.42 to −0.20) and BMI (MD = −0.49 kg/m²; 95% CI, −0.83 to −0.15) reductions.
- After excluding a crossover trial and studies with sample sizes < 50, the CAP difference was no longer statistically significant (MD = −11.97; 95% CI, −31.08 to 7.14; p = 0.22). Risk of bias was low in 2 studies (22.2%) and raised some concerns in 7 (77.8%).
Methods
- Systematic review and meta-analysis following PRISMA and prospectively registered in PROSPERO (CRD420251149184); PubMed, Embase, Web of Science, and Cochrane Central were searched from inception to August 1, 2025.
- Eligible studies were randomized controlled trials in adults with NAFLD, MAFLD, or MASLD comparing IF regimens (TRF, ADF, or WDF) with CER; two reviewers independently screened, selected, and extracted data.
- Random-effects models pooled mean differences with 95% CIs; heterogeneity was assessed with I²; prespecified subgroup and sensitivity analyses were performed, risk of bias was assessed with RoB 2, and GRADE was used for certainty of evidence. Included trials: 9 RCTs (n = 894; 508 IF, 386 CER), 8 parallel-group and 1 crossover, intervention durations 8–52 weeks, mean age 31–61 years, median BMI 26–33 kg/m².
Limitations
- The paper states that CAP significance diminished after sensitivity testing, residual heterogeneity persisted despite subgroup stratification, most studies were relatively short duration, and several included studies had small sample sizes, increasing susceptibility to small-study effects.
- The paper states that blinding of participants and personnel was generally infeasible for dietary interventions; main sources of bias were insufficient reporting of outcome assessor blinding and unclear handling of missing data.
- Evident from the text: CAP and MRI-PDFF gave discordant results for hepatic steatosis, energy intake was not uniformly matched or reported across trials, and adherence was not uniformly reported, which limits interpretation of subgroup differences such as the apparent TRF advantage.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
9 Valid · 0 Not valid · 7 Not checked · 66 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant between-group differences were observed for magnetic resonance imaging–proton density fat fraction (MRI-PDFF)”
- Also stated in: § Effects on hepatic fat content · plain
“By contrast, MRI-PDFF did not differ significantly between IF and CER in the overall analysis (MD = −0.08%; 95% CI, −1.65 to 1.48; k = 4; p = 0.918; I2 = 56.6%; Supplementary Figure S1B).”
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effects on hepatic fat content · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LDL-C (MD = −0.08 mmol/L; 95% CI, −0.15 to −0.01)”
- Also stated in: § Effects on lipid metabolism · plain
“Among lipid outcomes, only LDL-C demonstrated a modest reduction with IF compared with CER (MD = −0.08 mmol/L; 95% CI, −0.15 to −0.01; k = 10; p = 0.027; I2 = 0.0%; Supplementary Figure S5A).”
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effects on lipid metabolism · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant between-group differences were observed for magnetic resonance imaging–proton density fat fraction (MRI-PDFF), liver stiffness, transaminases, glucose-related indices, total cholesterol, triglycerides, or HDL-C.”
- Also stated in: § Effects on liver stiffness and transaminases · plain
“Changes in LSM did not differ significantly between IF and CER (MD = −0.41 kPa; 95% CI, −1.07 to 0.25; k = 9; p = 0.228; I2 = 75.8%; Supplementary Figure S2A).”
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effects on liver stiffness and transaminases · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, IF resulted in a modest but nonsignificant reduction in ALT compared with CER (MD = −3.23 U/L; 95% CI, −6.55 to 0.09; k = 8; p = 0.057; I2 = 0.0%; Supplementary Figure S2B).”
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Results > Effects on liver stiffness and transaminases
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI (MD = −0.34 kg/m2; 95% CI, −0.55 to −0.13)”
- Also stated in: § Effects on body weight and BMI · plain
“Similarly, IF significantly reduced BMI compared with CER (MD = −0.34 kg/m2; 95% CI, −0.55 to −0.13; k = 8; p = 0.002; I2 = 0.0%; Supplementary Figure S3B).”
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effects on body weight and BMI · plain
33 more claims
Create a free account to see all 82 claims and to verify the 2 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 32
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Results > Study characteristics
“Seven trials found no significant between-group differences in energy intake during the intervention (21, 24, 25), in change from baseline (16, 18, 25), or in post-intervention energy intake (20, 22)”
§ Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis > Results > Study characteristics
“whereas two studies reported lower caloric intake in the IF groups than in the CER groups (23, 24).”
Citations
Cites
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · cited 1×
“Evidence suggests that a 7–10% weight reduction can significantly alleviate hepatic steatosis and inflammation (7).”
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Effects of intermittent fasting on health, aging, and disease
de Cabo, R., & Mattson, M. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1905136 · Cited by 1,605
Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.022 · Cited by 1,275 · cited 1×
“In individuals with obesity or more advanced steatosis, CAP measurements may be less reliable due to increased signal attenuation and technical limitations, whereas MRI-PDFF is less affected by these factors and maintains higher precision (31, 32).”
Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan
Longo, V. D., & Panda, S. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.001 · Cited by 1,013 · cited 1×
“This metabolic switching promotes the release and utilization of fatty acids and ketone bodies—signaling molecules that may regulate diverse cellular pathways, enhance stress resistance, improve organ function, and protect against metabolic and inflammatory diseases (12, 44, 45).”
Metabolic Effects of Intermittent Fasting
Patterson, R. E., & Sears, D. D. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064634 · Cited by 810 · cited 1×
“This process suppresses very-low-density lipoprotein cholesterol (VLDL-C) synthesis, thereby lowering circulating LDL-C levels (28, 40).”
Current status and future trends of the global burden of MASLD
Miao, L., Targher, G., Byrne, C. D., Cao, Y.-Y., & Zheng, M.-H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.007 · Cited by 781
Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23052 · Cited by 776
Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting
Anton, S. D., Moehl, K., Donahoo, W. T., Marosi, K., Lee, S. A., Mainous, A. G., Leeuwenburgh, C., & Mattson, M. P. (2018) · Obesity · doi:10.1002/oby.22065 · Cited by 756 · cited 1×
“This pattern may reflect the longer fasting duration in WDF, which could theoretically enhance metabolic switching, lipid mobilization, and hepatic fatty acid oxidation (34).”
Noureddin, M., Lam, J., Peterson, M. R., Middleton, M., Hamilton, G., Le, T.-A., Bettencourt, R., Changchien, C., Brenner, D. A., Sirlin, C., et al. (2013) · Hepatology · doi:10.1002/hep.26455 · Cited by 550
Dynamics of human adipose lipid turnover in health and metabolic disease
Arner, P., Bernard, S., Salehpour, M., Possnert, G., Liebl, J., Steier, P., Buchholz, B. A., Eriksson, M., Arner, E., Hauner, H., et al. (2011) · Nature · doi:10.1038/nature10426 · Cited by 400 · cited 1×
“During feeding, carbohydrates and lipids are mainly stored in the liver, skeletal muscle, and adipose tissue, whereas during fasting, the body depends on glycogenolysis and triglyceride mobilization to supply substrates for oxidative metabolism (42, 43).”
INTERMITTENT FASTING AND HUMAN METABOLIC HEALTH
Patterson, R. E., Laughlin, G. A., LaCroix, A. Z., Hartman, S. J., Natarajan, L., Senger, C. M., Martínez, M. E., Villaseñor, A., Sears, D. D., Marinac, C. R., et al. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.018 · Cited by 390 · cited 1×
“ADF alternates fasting or calorie-restricted days with ad libitum feeding days, whereas WDF restricts caloric intake on two nonconsecutive days per week while permitting unrestricted eating on the remaining 5 days (11, 13, 14).”
Effects of intermittent fasting on body composition and clinical health markers in humans
Tinsley, G. M., & La Bounty, P. M. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv041 · Cited by 382 · cited 2×
“ADF alternates fasting or calorie-restricted days with ad libitum feeding days, whereas WDF restricts caloric intake on two nonconsecutive days per week while permitting unrestricted eating on the remaining 5 days (11, 13, 14).”
Time-restricted eating for the prevention and management of metabolic diseases
Manoogian, E. N. C., Chow, L. S., Taub, P. R., Laferrère, B., & Panda, S. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab027 · Cited by 344
Patikorn, C., Roubal, K., Veettil, S. K., Chandran, V., Pham, T., Lee, Y. Y., Giovannucci, E. L., Varady, K. A., & Chaiyakunapruk, N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.39558 · Cited by 298 · cited 1×
“Notably, the TRF subgroup in our analysis showed the largest pooled effect on body weight, whereas previous meta-analyses in healthy or obese adults often found ADF to be most effective (38, 39).”
Petroff, D., Blank, V., Newsome, P. N., Shalimar, Voican, C. S., Thiele, M., de Lédinghen, V., Baumeler, S., Chan, W. K., Perlemuter, G., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30357-5 · Cited by 268 · cited 1×
“CAP quantifies ultrasound attenuation and is more susceptible to operator dependence, probe selection, and technical variability, and its performance may be influenced by patient characteristics such as body mass index (BMI) and the degree of hepatic steatosis (30).”
Holmer, M., Lindqvist, C., Petersson, S., Moshtaghi-Svensson, J., Tillander, V., Brismar, T. B., Hagström, H., & Stål, P. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100256 · Cited by 224 · cited 1×
“Meanwhile, randomized clinical studies have suggested that intermittent calorie restriction may improve liver-related outcomes in patients with NAFLD, further supporting the potential role of fasting-based dietary strategies in this population (8).”
Cai, H., Qin, Y.-L., Shi, Z.-Y., Chen, J.-H., Zeng, M.-J., Zhou, W., Chen, R.-Q., & Chen, Z.-Y. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1132-8 · Cited by 205 · cited 2×
“Four studies reported changes in energy intake from baseline (16, 18, 23, 25), two provided both baseline and end-of-intervention values (22, 25), and three reported mean energy intake across the intervention period (19, 21, 24).”
Adipose lipid turnover and long-term changes in body weight
Arner, P., Bernard, S., Appelsved, L., Fu, K.-Y., Andersson, D. P., Salehpour, M., Thorell, A., Rydén, M., & Spalding, K. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0565-5 · Cited by 155 · cited 1×
“During feeding, carbohydrates and lipids are mainly stored in the liver, skeletal muscle, and adipose tissue, whereas during fasting, the body depends on glycogenolysis and triglyceride mobilization to supply substrates for oxidative metabolism (42, 43).”
Wei, X., Lin, B., Huang, Y., Yang, S., Huang, C., Shi, L., Liu, D., Zhang, P., Lin, J., Xu, B., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.3513 · Cited by 149 · cited 2×
“Four studies reported changes in energy intake from baseline (16, 18, 23, 25), two provided both baseline and end-of-intervention values (22, 25), and three reported mean energy intake across the intervention period (19, 21, 24).”
Elortegui Pascual, P., Rolands, M. R., Eldridge, A. L., Kassis, A., Mainardi, F., Lê, K., Karagounis, L. G., Gut, P., & Varady, K. A. (2023) · Obesity · doi:10.1002/oby.23568 · Cited by 133
Amino acids control blood glucose levels through mTOR signaling
Fan, J., Yuan, Z., Burley, S. K., Libutti, S. K., & Zheng, X.-F. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151240 · Cited by 112
Morales‐Suárez‐Varela, M., Sánchez, E. C., Peraita‐Costa, I., González, A. L., & Soriano, J. M. (2021) · Nutrients · doi:10.3390/nu13093179 · Cited by 104 · cited 1×
“In MASLD, where obesity and insulin resistance are key drivers, our results likewise suggest that IF may provide metabolic benefits compared with CER (37).”
Harris, L., McGarty, A. M., Hutchison, L., Ells, L. J., & Hankey, C. R. (2017) · Obesity Reviews · doi:10.1111/obr.12593 · Cited by 81 · cited 2×
“Our findings regarding body weight align with previous meta-analyses reporting greater weight loss with IF compared with CER in both healthy and overweight populations (27, 29, 35).”
A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis
Loft, A., Schmidt, S. F., Caratti, G., Stifel, U., Havelund, J., Sekar, R., Kwon, Y., Sulaj, A., Chow, K. K., Alfaro, A. J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.004 · Cited by 76
Enríquez Guerrero, A., San Mauro Martín, I., Garicano Vilar, E., & Camina Martín, M. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00821-1 · Cited by 75
Lin, L., Shi, L., Chu, H., & Murad, M. H. (2019) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2019-111191 · Cited by 74 · cited 1×
“Second, with a limited number of included studies, pooled estimates may be highly sensitive to small-study effects or potential publication bias, which may contribute to both apparent significance and increased heterogeneity (33).”
Colantoni, A., Bucci, T., Cocomello, N., Angelico, F., Ettorre, E., Pastori, D., Lip, G. Y. H., Ben, M. D., & Baratta, F. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02263-6 · Cited by 69 · cited 1×
“Given that MASLD pathogenesis involves complex interactions among lipid metabolism, insulin sensitivity, and inflammation (41), more prolonged interventions may be necessary to reveal significant differences in these parameters.”
Schroor, M. M., Joris, P. J., Plat, J., & Mensink, R. P. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2023.10.003 · Cited by 61
Schwingshackl, L., Zähringer, J., Nitschke, K., Torbahn, G., Lohner, S., Kühn, T., Fontana, L., Veronese, N., Schmucker, C., & Meerpohl, J. J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1757616 · Cited by 53 · cited 2×
“This process suppresses very-low-density lipoprotein cholesterol (VLDL-C) synthesis, thereby lowering circulating LDL-C levels (28, 40).”
Intermittent fasting versus continuous calorie restriction: which is better for weight loss?
Zhang, Q., Zhang, C., Wang, H., Ma, Z., Liu, D., Guan, X., Liu, Y., Fu, Y., Cui, M., & Dong, J. (2022) · Nutrients · doi:10.3390/nu14091781 · Cited by 53
Lange, M., Nadkarni, D., Martin, L., Newberry, C., Kumar, S., & Kushner, T. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000212 · Cited by 49 · cited 10×
“The terms NAFLD and MAFLD are retained only where appropriate, such as in the description of prior studies or diagnostic criteria.”
InfluentialThe future of obesity: new drugs versus lifestyle interventions
Scheen, A. J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.263 · Cited by 47 · cited 1×
“However, maintaining long-term adherence is challenging, as compliance often declines over time (9).”
Feehan, J., Mack, A., Tuck, C., Tchongue, J., Holt, D. Q., Sievert, W., Moore, G. T., de Courten, B., & Hodge, A. (2023) · Nutrients · doi:10.3390/nu15234870 · Cited by 47
Pharmacological treatment of MASLD: contemporary treatment and future perspectives
Drygalski, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136518 · Cited by 39
Oh, J. H., Yoon, E. L., Park, H., Lee, S., Jo, A. J., Cho, S., Kwon, E., Nah, E.-H., Lee, J.-H., Park, J. H., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.06.005 · Cited by 30 · cited 3×
“Eight trials employed a parallel-group design (16, 18–24), and one utilized a crossover design (25).”
Saleh, S. A. K., Santos, H. O., Găman, M., Cerqueira, H. S. C., Zaher, E. A., Alromaih, W. R., Arafat, N. S., Adi, A. R., Adly, H. M., Alyoubi, R. A., et al. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.11.009 · Cited by 30
Sun, X., Li, F., Yan, H., Chang, X., Yao, X., Yang, X., Wu, S., Suo, Y., Zhu, X., Wang, C., et al. (2025) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.10.012 · Cited by 30 · cited 4×
“For example, Sun et al. reported a randomized clinical trial comparing intermittent versus continuous calorie restriction in patients with MASLD, further expanding the disease-specific evidence base (16).”
InfluentialWang, Y.-Y., Tian, F., Qian, X.-L., Ying, H.-M., & Zhou, Z.-F. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1439473 · Cited by 28
Abuelazm, M. T., Mohamed, I., Naeem, A., Khlidj, Y., Tanashat, M., Katamesh, B. E., Abusuilik, H., Altobaishat, O., Abdelnabi, M., & Abdelazeem, B. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002715 · Cited by 21 · cited 3×
“Previous meta-analyses have investigated the effects of IF on hepatic and metabolic outcomes in various populations (15, 17, 26), and several studies have compared intermittent energy restriction (IER) with CER across metabolic disorders (27–29).”
Xu, R., Cao, Y., Wang, P., Chen, X., & Tao, D. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1090792 · Cited by 13 · cited 1×
“Schwingshackl et al. (28) reported small but significant weight loss with IER in over-weight and obese individuals, while Xu et al. (36) demonstrated that IF may be more effective than CER in improving body weight and metabolic syndrome parameters.”
Karimi, M., Akhgarjand, C., Houjaghani, H., Nejad, M. M., Sohrabpour, A. A., Poustchi, H., Mohammadi, H., Chamari, M., & Imani, H. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.01.007 · Cited by 12 · cited 1×
“Four studies reported changes in energy intake from baseline (16, 18, 23, 25), two provided both baseline and end-of-intervention values (22, 25), and three reported mean energy intake across the intervention period (19, 21, 24).”
Lee, H. A., Moon, H., Kim, Y., Lee, J. K., Lee, H. A., & Kim, H. Y. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.051 · Cited by 9 · cited 2×
“Four studies reported changes in energy intake from baseline (16, 18, 23, 25), two provided both baseline and end-of-intervention values (22, 25), and three reported mean energy intake across the intervention period (19, 21, 24).”
Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F. (2025) · Life · doi:10.3390/life15050696 · Cited by 9
Metadata
- Authors
- Li, H., & Li, T.
- Affiliations
- Chongqing Medical University (CN)
- Corresponding author
- Li, Tianju
- ORCID
- Venue
- Frontiers in nutrition
- Publisher
- Frontiers Media SA
- Published
- 2026-05-13
- Volume
- 13
- Pages
- 1833688-1833688
- ISSN
- 2296-861X (ISSN-L)
- PMC
- PMC13213722
- OpenAlex
- W7161060364
- Semantic Scholar
- ed9d7fea0d9757150ae8b36db4b6ce30375c9f57
- Cited by
- 1
- References
- 47
- Citations by year
- 2026: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Nutrition (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- intermittent fasting, continuous energy restriction, non-alcoholic fatty liver disease, hepatic steatosis, controlled attenuation parameter, LDL cholesterol, weight loss, dietary intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
